SCHEMBL17035083

SCHEMBL17035083

c1ccc(-c2nc3ccccc3c3c2ccc2c(-c4c5ccccc5c(-c5cc(-c6cccnc6)cc(-c6cccnc6)c5)c5ccccc45)cccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.41
CYP11B1 P15538 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP19A1 P11511 1/20 0.38
CYP2C9 P11712 6/20 0.38
HPGD P15428 2/20 0.38
F2 P00734 1/20 0.38
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
CLK4 Q9HAZ1 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP2D6 P10635 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.37
GLA P06280 1/20 0.37
KMT2A Q03164 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
CSNK2A2 P19784 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035081 0.95 DHODH (0.41) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17035127 0.91 DHODH (0.43) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17034987 0.87 DHODH (0.42) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17034986 0.87 DHODH (0.42) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17035095 0.85 CYP1A2 (0.44) DHODHCYP11B1CYP2A6CYP2C9HPGD
SCHEMBL17034965 0.84 CYP11B1 (0.43) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17034932 0.84 CYP2A6 (0.43) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL21935633 0.83 DHODH (0.47) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17035066 0.83 CYP11B1 (0.43) DHODHCYP11B1CYP2A6CYP19A1CYP2C9
SCHEMBL17034960 0.83 CYP11B1 (0.48) DHODHCYP11B1CYP2A6CYP19A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 DHODH 2312/4885CYP11B1 781/4885CYP2A6 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.